BUB1 serves as a biomarker for poor prognosis in liver hepatocellular carcinoma
Our present study demonstrated that BUB1 is a potential prognostic biomarker, and BUB1 may play a role in the tumor immune microenvironment in HCC.
Authors
- Jingbin Ni
- Yuzheng Zhuge (ORCID: https://orcid.org/0000-0002-3829-5831)
- Lili Zhang (ORCID: https://orcid.org/0000-0002-9341-5832)
Institutions
- Jiangnan University (CN)
- Nanjing Drum Tower Hospital (CN)
- Wuxi No.2 People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Immunology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1186/s12865-025-00698-4
- Citations
- 6
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 6.91